Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hempdocon Aug 19, 2020 2:45pm
234 Views
Post# 31429951

RE:RE:RE:RE:Corona Virus news

RE:RE:RE:RE:Corona Virus news
jicoop wrote: Would this not be a great time to introduce TLD1633 ? What ever happened to that promising compound, better than 1433 , and the one than was Billions times more effective, going back to 2017 and 18 . Disappeared ?  

Coop

Eoganacht wrote: Even if everything goes very well, it will be a long haul from the start of animal testing to approval to commercialize a treatment for humans. But it's a very worthwhile endeavour however long it takes. This could be the start of Theralase's anti-viral/anti-bacterial solution.

jojomarch wrote:
the Company looks forward to introducing this game changing technology to the world in due course. I have 2 microcaps in my financial portfolio and I am in a " show me mode " . After almost 6 years of TLT ownership , I will believe it when I see it . Like many here I own a lot shares so if they succeed we will be rewarded . Sorry to be sceptical but TLT , like politicians , has over promised and under delivered so far IMO . GLTA GLTA

 




I think they will use it for GBM since it was noted to be 15% more effective & safer.  There is no question that Sherri M. & the team have every intention to expand TLT's PDC portfolio, including TLD-1633 & others. 

Bullboard Posts